Postgraduate Course ERS Copenhagen 2005 - Therapeutic options for interstitial lung diseases in 2005

نویسنده

  • R. P. Baughman
چکیده

The decision to treat a patient with sarcoidosis is dependent on many factors, the most important being whether the patient is symptomatic. Initial systemic therapy for symptomatic sarcoidosis usually includes corticosteroids. However, most symptomatic patients will require months to years of therapy. Therefore, alternatives to corticosteroids have been studied. This review will give a brief overview of the effect of corticosteroids and alternative treatments options available. Postgraduate Course ERS Copenhagen 2005

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Interstitial lung diseases: course report

ERS hosted a 3-day course on interstitial lung diseases in Heidelberg, Germany http://ow.ly/M8MD3021q6n.

متن کامل

International Congress of Airway & Interstitial Lung Diseases (ICAILD 2018)

“International Congress of Airway & Interstitial Lung Diseases” took place on November 14-16, 2018, in Pardisan Hotel,Mashhad,Iran. Hosted in our home city of Mashhad, the second largest city, in the North East of Iran. It is famous for the holy shrine of Imam Reza as well as Toos,the residence of Ferdowsi, the great Persian poet. The congress scientific program presented the best in science an...

متن کامل

Pulmonary hypertension in interstitial lung disease.

Pulmonary hypertension (PH) may complicate the course of many forms of advanced interstitial lung disease (ILD) and has been shown to portend a worse outcome. The aetiology of PH is likely multifactorial with variable contribution of factors amongst the different diseases. The most common such conditions include idiopathic pulmonary fibrosis, sarcoidosis, connective tissue disease-related ILD a...

متن کامل

Serum biomarkers in interstitial lung diseases

The use of biomarkers in medicine lies in their ability to detect disease and support diagnostic and therapeutic decisions. New research and novel understanding of the molecular basis of the disease reveals an abundance of exciting new biomarkers who present a promise for use in the everyday clinical practice. The past fifteen years have seen the emergence of numerous clinical applications of s...

متن کامل

Favorable outcomes with tacrolimus in two patients with refractory interstitial lung disease associated with polymyositis/dermatomyositis.

Two cases of progressive interstitial lung disease associated with polymyositis/dermatomyositis are presented. Both patients were refractory to conventional therapy with high-dose corticosteroids, cyclosporine, and intermittent pulse cyclophosphamide, and thus a therapeutic trial of tacrolimus was instituted. Tacrolimus was markedly effective in achieving subjective, laboratory and radiographic...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2006